Similar articles

• [Experimental model on DTPA therapy of radioactivity contaminated wounds].

  Bömer H. Bömer H. Strahlentherapie. 1972 Jun;143(6):664-9. Strahlentherapie. 1972. PMID: 5071563 German. No abstract available.
• Interpretation of human urinary excretion of plutonium for cases treated with DTPA.

  Jech JJ, Andersen BV, Heid KR. Jech JJ, et al. Health Phys. 1972 Jun;22(6):787-92. doi: 10.1097/00004032-197206000-00039. Health Phys. 1972. PMID: 5084012 No abstract available.
• Urinary excretion of 241Am under DTPA therapy.

  Fasiska BC, Bohning DE, Brodsky A, Horm J. Fasiska BC, et al. Health Phys. 1971 Oct;21(4):523-9. doi: 10.1097/00004032-197110000-00003. Health Phys. 1971. PMID: 5115125 No abstract available.
• Biokinetic modelling of DTPA decorporation therapy: the CONRAD approach.

  Breustedt B, Blanchardon E, Berard P, Fritsch P, Giussani A, Lopez MA, Luciani A, Nosske D, Piechowski J, Schimmelpfeng J, Sérandour AL. Breustedt B, et al. Radiat Prot Dosimetry. 2009 Feb;134(1):38-48. doi: 10.1093/rpd/ncp058. Epub 2009 Apr 7. Radiat Prot Dosimetry. 2009. PMID: 19351653 Review.
• Types of exposure models and advantages and disadvantages of sources of exposure data for use in occupational reproductive studies.

  Lemasters GK, Selevan SG. Lemasters GK, et al. Prog Clin Biol Res. 1984;160:67-79. Prog Clin Biol Res. 1984. PMID: 6382341 Review. No abstract available.